A 4-year-old boy presents with hepatomegaly, growth retardation, and fasting hypoglycemia. His parents report that he becomes irritable and sweaty 2–3 hours after meals. Serum lactate is elevated at 5 mmol/L (normal <2). Which investigation is most appropriate to confirm the suspected glycogen storage disorder?

## Diagnostic Approach to Glycogen Storage Disorders **Key Point:** Liver biopsy with histochemistry and enzyme assay remains the gold standard for definitive diagnosis of glycogen storage disorders, particularly when the clinical and biochemical picture is suggestive. ### Clinical Context The presentation of hepatomegaly, fasting hypoglycemia, lactic acidosis, and growth retardation is classic for **Type I GSD (von Gierke disease)**, caused by glucose-6-phosphatase deficiency. The elevated lactate and severe fasting hypoglycemia are pathognomonic. ### Why Liver Biopsy Is Diagnostic | Investigation | Diagnostic Yield | Specificity | Timing | | --- | --- | --- | --- | | **Liver biopsy + histochemistry** | Definitive (shows glycogen accumulation pattern) | High (enzyme assay identifies specific defect) | Gold standard | | Serum glucose/insulin during fast | Supportive (confirms hypoglycemia + hyperinsulinemia) | Low (non-specific) | Screening only | | MR spectroscopy | Supportive (shows hepatic steatosis) | Low (non-specific) | Adjunctive | | Genetic testing | Definitive but slow | High | Confirmatory (not first-line) | **High-Yield:** Liver biopsy allows: 1. **Histochemical staining** (PAS stain) to visualize glycogen accumulation and architecture 2. **Enzyme assay** on fresh tissue to measure glucose-6-phosphatase, phosphorylase, or other deficient enzymes 3. **Electron microscopy** to assess glycogen particle size and distribution ### Why Other Options Are Incorrect **Serum glucose and insulin during fast:** - Confirms the metabolic derangement but does NOT identify the specific enzyme defect - Cannot differentiate between Type I, III, VI, or IX GSD - Useful for screening but not diagnostic **MR spectroscopy:** - Shows hepatic steatosis and glycogen accumulation indirectly - Cannot identify the underlying enzyme deficiency - Supportive but not diagnostic **Genetic testing for GYS1 mutations:** - GYS1 encodes glycogen synthase (Type IV GSD) - This patient's presentation (severe fasting hypoglycemia, lactic acidosis) is NOT consistent with Type IV - Genetic testing is appropriate AFTER enzyme defect is identified by biopsy - Too time-consuming as first-line investigation **Clinical Pearl:** In modern practice, genetic testing is increasingly used as a confirmatory tool after enzyme assay suggests a specific GSD. However, in resource-limited settings and for rapid diagnosis, liver biopsy with enzyme assay remains the fastest and most cost-effective definitive test. **Mnemonic — GSD Diagnosis Strategy: BIOPSY-FIRST** - **B** — Biopsy (liver) is gold standard - **I** — Identify enzyme defect via assay - **O** — Observe glycogen pattern on histology - **P** — Pursue genetic confirmation if needed - **S** — Serum markers (lactate, glucose) are supportive only - **Y** — Yield is highest with tissue-based diagnosis - **F** — First-line investigation in suspected GSD - **I** — Imaging (MRI) is adjunctive - **R** — Rapid enzyme assay on fresh biopsy - **S** — Specific enzyme defect identified - **T** — Then genetic testing for confirmation